Tony Ting

Company: Kiji Therapeutics

Job title: Chief Scientific Officer

Seminars:

Implementing In Vivo Disease Models in Treatment Analysis to Assess the Quality of Developing Treatments 4:30 pm

Discussing the ability of GvHD and IBD mouse models in replicating complex immunecell interactions Exploring the potential of mouse models to assess treatment efficacy, persistence and safety Highlighting IL-10 expressing cell therapy preclinical data showcasing efficacy using preclinical modelsRead more

day: Conference Day One PM